Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

NCT01470612 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

944

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: CP-690,550
DRUG: CP-690,550

Sponsor

Pfizer